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Highlights
 Intracellular renin and angiotensin disrupts chemical communication in heart.
 Epigenetic modification of renin angiotensin aldosterone system (RAAS) and heart
disease.
 Intracrine renin angiotensin and metabolic cooperation.
 Gap junction, intracellular renin and angiotensin, cellular patterns, and heart
development.
The finding that intracellular renin and angiotensin II (Ang II) disrupts chemical com-
munication and impairs metabolic cooperation between cardiomyocytes induced by
aldosterone, hyperglycemia, and pathological conditions like myocardial ischemia is
discussed. The hypothesis is presented that epigenetic changes of the renin angiotensin
aldosterone system (RAAS) are responsible for cardiovascular abnormalities, including the
expression of RAAS components inside cardiac myocytes (intracrine RAAS) with serious
consequences including inhibition of electrical and chemical communication in the heart,
resulting in metabolic disarrangement and cardiac arrhythmias. Moreover, the inhibition
of gap junctional communication induced by intracellular Ang II or renin can contribute to
the selection of cellular patterns during heart development.
Keywords: chemical, communication, heart, cell, metabolic cooperation
Gap Junctions and Cellular Patterns
Cells are functional units, which play a fundamental role on tissue and organ functions. The
cellular arrangement established during embryonic development is governed by several genes, which
regulate the properties of surface cell membrane including the expression of receptors and ligand
molecules such as glycoproteins which make possible the recognition and the interaction between
cells. In this process, chemical communication between cells play an important role making possible
the establishment of cellular patterns, which are essential for tissue and organ development (1, 2).
The synthesis of intercellular channels (gap junctions) contributes to the metabolic cooperation
between cells through the spread of ions and small molecules such as amino acids, hormones, and
nucleotides from cell-to-cell (3). Recently, evidence has been presented that much larger molecules
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such as peptides and microRNA are able to diffuse through gap
junctions (4, 5). Because microRNA-133a engineered mesenchy-
mal stem cells augment cardiac function and cell survival in
the infarct heart (6), it is conceivable that the transfer of larger
molecules through gap junctions represents an important aspect
of metabolic cooperation in health and disease in part by modu-
lating renin angiotensin aldosterone system (RAAS) (7). Indeed,
novel evidence thatmiRNAs are important regulators of biological
processes involved in cardiovascular disease via genetic control is
now available (7).
The gap junction permeability is modulated by different factors
such as intracellular Ca concentration and cyclic AMP, which
enhances the permeability of intercellular channels through the
phosphorylation of the gap junction proteins (connexins) (8, 9).
Recently, it was found that high glucose inhibits chemical com-
munication between heart cells including the intercellular flow of
glucose (10) –an effect partially explained by hyperphosphory-
lation of gap junction proteins but also due to intracellular Ang
II generated by high glucose (10). The evidence now available
that glucose flows from cell-to-cell through gap junctions (11)
indicates that the exchange of energy substrate between cells is an
important mechanism of tissue homeostasis, particularly during
ischemic conditions when glucose becomes an important source
of energy.
Angiotensin II, Gap Junctions, and
Epigenetic Factors
The transfer of chemical signals between cells seems to play a
decisive role during tissue regeneration (3), and more recently,
evidence has been provided that misregulation of the gap junction
protein connexin43 (Cx43), when DNA sequence of the Cx gene
itself is unaltered (12), changes cardiogenesis. Over the past few
years, important knowledge about the epigenetic regulation of
heart development and disease has been achieved. It is known,
for instance, that DNA methylation, chromatin remodeling, and
histone modifications are involved in this process (13), and that
the reactivation of fetal genes are involved in the development of
heart failure and ventricular hypertrophy. It is also known that
different epigenetic factors like electric fields and pressure alter
cardiac morphology and functions through gap junctions (12),
and that there is an association between fetal insults to epigenetic
changes of genes with consequent generation of pathological pro-
cesses including hypertension (14). Evidence is available that in
maternal low protein diet rat models of programing, angiotensin
converting enzyme inhibitors or angiotensin receptor antagonists
administered early in life can prevent development of hyperten-
sion (14). It is then reasonable to think that cardiac abnormalities
can be generated by the modification of the RAAS elicited by
epigenetic factors. During early stages of embryonic development,
a large proportion of genes is demethylated, but during develop-
ment a selective methylation of unnecessary genes occurs in the
differentiated cell (14). Moreover, post translational changes of
calcium handling proteins, such as calstabin2, induced by epige-
netic factors can alter cardiac structure. Histological studies of the
heart revealed that aged Calstabin2 null mice exhibited large areas
of cell death myocardial fibrosis (15).
Because Ang II reduces the gap junction permeability, the pep-
tide can play a role during development impairing the transference
of chemical information between cardiac cells and contributing
to the selection of cellular patterns, which are essential during
embryonic development (1, 2). It is known that ACE and other
components of the renin angiotensin system are expressed in the
embryo after 30 days of gestation (16), and that Ang II plays a
role on the differentiation of embryonic stem cells into smooth
muscle cells (17) –an effect mediated by AT1 receptor (18).
In humans, AT1 and AT2 receptors are expressed early during
embryonic development (24 days of gestation) (19).Furthermore,
stress, in utero, can induce the later development of disease includ-
ing the overexpression of AT1b receptors in the adrenals and
hypertension (14).
RAAS, Metabolic Cooperation, and
Organogenesis
Evidence provided in recent decades revealed that local expres-
sion of renin angiotensin or aldosterone impairs communication
between heart cells by altering the gap junction conductance (20–
24). Angiotensin II, for instance, plays an important role on the
modulation of cell communication, inward calcium current, heart
contractility, and cell volume regulation in health and disease
through activation of cell surface AT1 receptors as well as PKC or
tyrosine kynases (22, 24, 25). The role of gap junctions, however,
is not limited to the spread of electrical currents between cardiac
cells, but is also involved in the exchange of chemical signals
including amino acids, nucleotides, and molecules up to 1000Da,
which can flow from cell-to-cell through gap junctions (9). This
means that cardiac cells exchange important metabolites, which
are vital for tissue function. The recent finding that intracellu-
lar renin and angiotensin II disrupts cell communication in the
heart, and is involved in cell volume regulation (25–27), indicates
that the presence of RAAS components inside the cardiac cell
(intracrine effect) has an important functional significance (22),
particularly during pathological conditions like cardiac failure,
when the heart tends to return to embryological conditions and
organogenesis is possible (28).
On the Possible Role of the Intracrine
RAAS
The presence of RAAS inside the cells, and the functional role of
intracellular renin and Ang II on the regulation of cell commu-
nication and inward calcium current lead to the concept of an
intracrine RAAS (11, 24, 29–32).The hypothesis outlined here is
that the intracrine renin–angiotensin system activated by aldos-
terone (21), hyperglycemia (33, 34), or by pathological conditions
like heart failure and myocardial ischemia [when a renin tran-
script is overexpressed (35, 36)] is part of the genetic makeup,
which is known to occur during these pathological conditions. It
is feasible that during pathological conditions, a drastic change
of intercellular chemical and electrical communication occurs,
involving second messengers and other signal molecules, which
are implicated in cell proliferation and growth. Supporting this
idea is the finding that angiotensin II, which is a growth factor,
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causes electrical uncoupling in the failing heart through the acti-
vation of AT1 receptors and intracellular pathways, such as PKC,
MAPK family, and increment of intracellular calcium (24), and
causes disruption of chemical communication between heart cells
(28). Similar effect was found when renin was dialyzed inside the
heart cells – an effect not necessarily related to Ang II formation
(37), but in part related to oxidative stress probably induced
by the activation of an intracellular renin receptor elicited by
renin (37, 38).
Studies of Schefe et al. (38) indicated that there is an intracel-
lular renin receptor, which when activated by intracellular renin,
causes the translocation of a transcription factor (PLZF) from the
cytoplasm to the nucleus, and consequent activation of several
genes including an enhanced transcription of the p85a subunit
of the phosphatidylinositol-3kinase(PI3K–p85a).Furthermore,
other studies (39) revealed that PI3K-Akt signaling activates
production of ROS by opening of themitochondrial ATP-sensitive
K channel (mKATP channel). It is reasonable to think that the
activation of pro (renin) receptor by renin within an intracellular
vesicle increases the oxidative stress through the PI3-Akt pathway
with consequent decrease of gap junction permeability [see Ref.
(37)] (see Figure 1).This finding is of particular interest because
previous studies revealed the presence of renin transcripts, which
encode a cytosolic protein that cannot be secreted (35). According
to these studies, these transcripts, which are derived from the
same renin gene using another promoter located within intron A,
are overexpressed during myocardial infarction (35), suggesting
a possible functional role of the enzyme. These isoforms of renin
are present in mitochondria, and are generated at free ribosomes
in the cytoplasm (36). It is known that different components
of the RAAS can be transported intracellularly via secretory
vesicles to mitochondria or to the nucleus, and that the activation
of the mitochondrial Ang system is coupled to mitochondrial
nitric oxide production. Furthermore, the binding of Ang II
to mitochondrial AT2 receptors stimulates NO formation with
consequent suppression of mitochondrial oxygen consumption
(40). Considering the role of Ang II on oxidative stress, it is
reasonable to think that the activation of AT1 or AT2 receptors in
mitochondria might be involved in the etiology of cardiovascular
disease.
ACE/Ang II/AT1 Receptor Axis Versus
ACE2/Ang(1-7)/Mas Receptor Axis
Evidence is now available that the formation of angiotensin (1–
3, 8, 9, 12, 20) [Ang (1–7) elicited by the activation of ACE2
(39)] has beneficial effects in the heart (39, 41, 42), counteracting
the harmful effects of Ang II (43) and re-establishing impulse
conduction during myocardial ischemia (42) as well as after cell
swelling (44). It is then conceivable that Ang (1–7) can play a
role in the formation of functional cellular patterns in the adult
heart by enhancing gap junction permeability with consequent
improvement of metabolic cooperation between cardiac cells. The
mechanism by which Ang (1–7) enhances gap junction perme-
ability involves activation of PKA and phosphorylation of gap
junction channels (44).
The possible role of ACE2/Ang (1–7) axis activation during
embryological development cannot be discarded because recent
studies revealed that ACE2 contributes to the postnatal devel-
opment of the heart, enhances coronary artery remodeling, and
causes cardiac hypertrophy (45, 46). In theACE2 knockout animal
model, for instance, a mild left ventricular wall thinning, ventric-
ular dilation, and reduction of heart contractility as well as, and
gene expression of the hypoxia-genes have beendescribed (45, 46).
FIGURE 1 | Diagram illustrating the influence of intracellular renin
due to internalization or to expression of renin transcript on
chemical communication between heart cells. The interaction
between renin and pro (renin) receptor occurring inside a cytoplasmic
vesicle can induce: the formation of Ang II, and the translocation of PLZF to
the nucleus [see Ref. (38)], and consequent generation of oxidative stress
through PI3K-Akt pathway with consequent decline of gap junction
communication.
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FIGURE 2 | Diagram illustrating the role of epigenetic factors, hyperglycemia, aldosterone and heart failure on the expression of renin and
angiotensin II in heart cells with consequent disruption of chemical communication and metabolic cooperation.
Recently, Ang (1–7) has been found in the nuclei of NRK-
52E renal epithelial cells (47), but the precise meaning of this
finding is not known. The possibility that the heptapeptide
be internalized cannot be discarded because internalization of
Mas receptors through a clathrin-mediated pathway has been
described when activated by Ang (1–7) (48).Because it is known
that gap junctions are synthesized within minutes (29, 49–51)
(half-life <5 h) followed by their return into the cell (51) uti-
lizing the endocytic clathrin machinery (52), it is plausible to
assume that the establishment of functional cellular pathways,
which is a dynamic process, can be generated by the activa-
tion of the ACE2/Ang (1-7)/Mas receptor axis. The activation
of the ACE/Ang II/AT1receptor axis, on the other hand, with
consequent formation of angiotensin II and aldosterone (21),
disrupts the exchange of chemical signals between heart cells and
contributes to the rupture of functional cellular patterns with
consequent inhibition of metabolic cooperation between cardiac
cells. The increment of oxidative stress seems to be an important
cause of disruption of cell communication (10, 37), and evidence
is available that Ang II receptors are involved in this process. The
binding of Ang II to mitochondria AT2 receptors (mtAT2Rs),
for instance, stimulates NO formation with consequent suppres-
sion of mitochondrial oxygen consumption (40), with serious
consequences for heart physiology. Considering the role of Ang
II on oxidative stress, it is reasonable to think that activation
AT1or AT2 receptors in mitochondria might be involved in the
etiology of heart disease including heart failure. It is known, for
instance, that AT1R blockade decreases RAS-mediated activation
of NADPH oxidase and oxidative stress, reducing left ventricular
fibrosis and mitochondrial remodeling (53). According to our
hypothesis, epigenetic factors as well as hyperglycemia, aldos-
terone, and heart failure, or ischemia lead to the expression of
renin and Ang II inside the cardiac cells with consequent decrease
of gap junction permeability, disruption of chemical communi-
cation, and consequent impairment of metabolic cooperation,
resulting in heart tissue dysfunction (see Figure 2). Furthermore,
the balance between ACE/Ang II/AT1 receptor axis and the
ACE2/Ang(1-7)/Mas receptor axis may play an essential role on
the formation of cellular patterns during embryological devel-
opment, but also in the differentiated heart by altering the gap
junction permeability and metabolic cooperation between cells
(see Figure 1).
Perspective
Future studies on the influence of intracellular renin and Ang
II on the interchange of chemical signals between cardiac cells
will provide a better knowledge of how metabolic cooperation
contributes to heart physiology and disease and will help the
development of novel therapeutic approaches for cardiac diseases.
Conclusion
(1) Intracellular renin disrupts the chemical communication
between heart cells with serious consequences formetabolic coop-
eration and electrical synchronization in the heart. The finding
that there is a renin transcript overexpressed during myocar-
dial infarction might indicate that an increase of renin inside
the heart cell is an important cause of functional disarrange-
ment; (2) gap junctions play an important role on metabolic
cooperation between heart cells and are involved in the estab-
lishment of cellular patterns during heart development as well
as in the adult heart; (3) the hypothesis is presented that epi-
genetic changes of the RAAS are responsible for hypertension
and cardiovascular abnormalities including the expression of
RAAS components inside cardiac myocytes (intracrine RAAS)
(see Figure 2); (4) diseases like hypertension, heart failure, and
myocardial ischemia induce the synthesis of RAAS components
in heart cells and causes severe abnormalities of tissue func-
tioning; (5) high glucose inhibits the chemical communication
between heart cells with serious implications for the diabetic
heart.
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